89 related articles for article (PubMed ID: 23143284)
1. Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference.
Toi M; Benson JR; Winer EP; Forbes JF; von Minckwitz G; Golshan M; Robertson JF; Sasano H; Cole BF; Chow LW; Pegram MD; Han W; Huang CS; Ikeda T; Kanao S; Lee ES; Noguchi S; Ohno S; Partridge AH; Rouzier R; Tozaki M; Sugie T; Yamauchi A; Inamoto T
Breast Cancer Res Treat; 2012 Dec; 136(3):919-26. PubMed ID: 23143284
[TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
3. Nonimage-guided fine needle aspiration biopsy of palpable axillary lymph nodes in breast cancer patients.
Marti JL; Ayo D; Levine P; Hernandez O; Rescigno J; Axelrod DM
Breast J; 2012; 18(1):3-7. PubMed ID: 22098412
[TBL] [Abstract][Full Text] [Related]
4. Surgical management of early stage invasive breast cancer: a practice guideline.
McCready D; Holloway C; Shelley W; Down N; Robinson P; Sinclair S; Mirsky D; ;
Can J Surg; 2005 Jun; 48(3):185-94. PubMed ID: 16013621
[TBL] [Abstract][Full Text] [Related]
5. Axillary and systemic treatment of patients with breast cancer and micrometastatic disease or isolated tumor cells in the sentinel lymph node.
Maaskant-Braat AJ; Voogd AC; van de Poll-Franse LV; Coebergh JW; Nieuwenhuijzen GA
Breast; 2012 Aug; 21(4):524-8. PubMed ID: 22516371
[TBL] [Abstract][Full Text] [Related]
6. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
7. Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study.
Unal B; Gur AS; Beriwal S; Tang G; Johnson R; Ahrendt G; Bonaventura M; Soran A
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1035-40. PubMed ID: 19327916
[TBL] [Abstract][Full Text] [Related]
8. [The advantages of preoperative systemic therapy in breast cancer].
Mieog JS; van Nes JG; van de Velde CJ
Ned Tijdschr Geneeskd; 2008 Nov; 152(46):2501-6. PubMed ID: 19055256
[TBL] [Abstract][Full Text] [Related]
9. Preoperative axillary staging in breast cancer-saving time and resources.
Tahir M; Osman KA; Shabbir J; Rogers C; Suarez R; Reynolds T; Bucknall T
Breast J; 2008; 14(4):369-71. PubMed ID: 18540958
[TBL] [Abstract][Full Text] [Related]
10. [Needle aspiration cytology of the breast: current perspective on the role in diagnosis and management].
Kocjan G
Acta Med Croatica; 2008 Oct; 62(4):391-401. PubMed ID: 19205416
[TBL] [Abstract][Full Text] [Related]
11. Controversies in the use of sentinel nodes: microinvasion, post surgery and after preoperative systemic treatment.
Veronesi P; Rodriguez-Fernandez J; Intra M
Breast; 2007 Dec; 16 Suppl 2():S67-70. PubMed ID: 17697779
[TBL] [Abstract][Full Text] [Related]
12. [Predictors of axillary node metastasis at breast surgery after neoadjuvant chemotherapy in patients with pre- chemotherapy-sentinel node positive breast cancer].
Tokita H; Aruga T; Yamashita T; Saji S; Suzuki E; Horiguchi K; Kitagawa D; Sekine S; Horiguchi S; Hirashima Y; Kuroi K
Gan To Kagaku Ryoho; 2011 Oct; 38(10):1639-45. PubMed ID: 21996959
[TBL] [Abstract][Full Text] [Related]
13. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.
Shen J; Gilcrease MZ; Babiera GV; Ross MI; Meric-Bernstam F; Feig BW; Kuerer HM; Francis A; Ames FC; Hunt KK
Cancer; 2007 Apr; 109(7):1255-63. PubMed ID: 17330229
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of fine-needle aspiration cytology of axillary lymph nodes in breast cancer patients: a study of 115 cases with cytologic-histologic correlation.
Alkuwari E; Auger M
Cancer; 2008 Apr; 114(2):89-93. PubMed ID: 18286535
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive axillary evaluation in neoadjuvant chemotherapy patients with ultrasonography and sentinel lymph node biopsy.
Khan A; Sabel MS; Nees A; Diehl KM; Cimmino VM; Kleer CG; Schott AF; Hayes DF; Chang AE; Newman LA
Ann Surg Oncol; 2005 Sep; 12(9):697-704. PubMed ID: 16079956
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
[TBL] [Abstract][Full Text] [Related]
17. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?
Specht MC; Fey JV; Borgen PI; Cody HS
J Am Coll Surg; 2005 Jan; 200(1):10-4. PubMed ID: 15631914
[TBL] [Abstract][Full Text] [Related]
18. New standards of care in the management of the axilla.
Thompson AM
Curr Opin Oncol; 2012 Nov; 24(6):605-11. PubMed ID: 22960559
[TBL] [Abstract][Full Text] [Related]
19. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
20. Can breast MRI predict axillary lymph node metastasis in women undergoing neoadjuvant chemotherapy.
Javid S; Segara D; Lotfi P; Raza S; Golshan M
Ann Surg Oncol; 2010 Jul; 17(7):1841-6. PubMed ID: 20143266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]